The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's total liabilities are $83.37 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $61.46 B | 12.84% |
2021-12-31 | $54.46 B | 1.73% |
2020-12-31 | $53.53 B | 7.01% |
2019-12-31 | $50.03 B | -7.2% |
2018-12-31 | $53.91 B | -1.46% |
2017-12-31 | $54.71 B | 14.58% |
2016-12-31 | $47.75 B | 9.79% |
2015-12-31 | $43.49 B | 0.61% |
2014-12-31 | $43.23 B | -1.81% |
2013-12-31 | $44.02 B | 24.95% |
2012-12-31 | $35.23 B | 18.08% |
2011-12-31 | $29.84 B | 52.71% |
2010-12-31 | $19.54 B | 15.21% |
2009-12-31 | $16.96 B | 5.64% |
2008-12-31 | $16.05 B | -4.25% |
2007-12-31 | $16.77 B | 13.13% |
2006-12-31 | $14.82 B | 67.58% |
2005-12-31 | $8.84 B | -7.04% |
2004-12-31 | $9.51 B | 40.2% |
2003-12-31 | $6.78 B | 10% |
2002-12-31 | $6.17 B | 403.33% |
2001-12-31 | $1.22 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $110.57 B | 32.63% | ๐บ๐ธ USA |
![]() Pfizer PFE | $101.28 B | 21.49% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $121.51 B | 45.75% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $41.86 B | -49.78% | ๐บ๐ธ USA |
![]() Biogen BIIB | $10.81 B | -87.03% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $40.93 B | -50.90% | ๐บ๐ธ USA |
![]() Illumina ILMN | $5.11 B | -93.86% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $62.39 B | -25.16% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $58.57 B | -29.75% | ๐ฌ๐ง UK |